New migraine drugs have promise — and a $8,500 price tag By: MarketWatch June 09, 2017 at 11:16 AM EDT They’re the first drugs developed for migraine in a long time. But migraine patients worry they won’t be able to access them. Read More >> Related Stocks: Alder Biopharma Allergan Plc Amgen Eli Lilly Teva Pharmaceutical Industries ADR